Resultats de la cerca - Weifan Ye

  • Mostrar 1 - 1 resultats de 1
Refinar resultats
  1. 1
    Phase II study of idelalisib, a selective inhibitor of PI3Kδ, for relapsed/refractory classical Hodgkin lymphoma

    Phase II study of idelalisib, a selective inhibitor of PI3Kδ, for relapsed/refractory classical Hodgkin lymphoma per Ajay K. Gopal, Michelle A. Fanale, Craig H. Moskowitz, Andrei R. Shustov, Siddhartha Mitra, Weifan Ye, Anas Younes, Alison J. Moskowitz

    Publicat 2017
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: